# DESCRIPTION

## FIELD OF THE INVENTION

- introduce MN gene and its relation to medical genetics and oncology

## BACKGROUND OF THE INVENTION

- motivate MN protein and its alternative names
- describe MN protein's carbonic anhydrase activity
- introduce G250 antigen and its relation to MN protein
- describe CA IX's discovery and biological nature
- discuss MN gene's presence in vertebrates and its correlation with tumorigenicity
- describe MN protein's expression in various human carcinomas
- discuss abnormal MN gene expression as a sign of oncogenesis
- introduce methods for detecting abnormal MN gene expression
- describe MN/CA IX's structure and function
- discuss MN cDNA sequence and genomic sequence
- introduce MN-specific antibodies and their production
- describe immunodominant epitopes of MN/CA IX
- discuss CA IX's enzymatic activity and its relation to carbonic anhydrase family
- describe CA IX's association with human tumors and its potential as a therapeutic target
- introduce alternative splicing as a molecular mechanism contributing to protein diversification

## SUMMARY OF THE INVENTION

- introduce CA9 mRNA transcripts
- describe full-length (FL) CA9 mRNA transcript
- describe alternatively-spliced (AS) CA9 mRNA transcript
- motivate therapeutic aspects of the invention
- introduce diagnostic/prognostic methods for preneoplastic/neoplastic diseases
- describe differentiating between FL and AS MN/CA IX expression
- introduce probes and/or primers to detect FL and/or AS MN/CA9 mRNA expression
- describe use of probes and/or primers to detect FL and/or AS MN/CA9 mRNA expression
- introduce nucleic acid amplification methods
- describe use of microarray chip
- introduce diagnostic/prognostic methods for preneoplastic/neoplastic diseases associated with abnormal MN/CA IX expression
- describe detecting or detecting and quantitating FL MN/CA IX protein but not AS MN/CA IX protein
- introduce antibodies or antibody fragments to differentiate between FL and AS MN/CA IX expression
- describe detecting or detecting and quantitating AS MN/CA IX protein but not FL MN/CA IX protein
- introduce nucleic acid probes and/or primers to differentiate between AS MN/CA9 mRNA and FL MN/CA9 mRNA expression
- describe therapeutic methods for treating preneoplastic/neoplastic disease

## Abbreviations

- define abbreviations
- list abbreviations

### Cell Lines

- list cell lines

### Nucleotide and Amino Acid Symbols

- explain nucleotide and amino acid symbols

## DETAILED DESCRIPTION

- describe MN/CA IX protein function
- introduce alternative splicing variant of CA9 mRNA

### Preneoplastic/Neoplastic Diseases

- list preneoplastic/neoplastic diseases associated with MN/CA IX

### Normoxia and Hypoxia

- define normoxia and hypoxia

### MN Gene and Protein

- define MN gene and protein
- describe MN cDNA sequence
- describe MN amino acid sequence
- describe MN genomic sequence
- describe MN protein structure
- describe MN gene cloning and sequencing
- discuss variations of MN nucleotide sequences
- describe exon-intron structure of MN genomic region
- map MN gene transcription initiation and termination sites
- describe mouse Car9 cDNA and gene
- describe organization of mouse Car9 gene
- define MN proteins and polypeptides
- describe features of MN proteins
- discuss variations of MN proteins
- outline recombinant production of MN proteins
- describe preparation of MN-specific antibodies
- define antibodies and their fragments
- discuss labeling of antibodies
- describe epitopes and their variations
- identify immunodominant epitopes in PG domain
- describe epitopes in neighboring regions
- discuss specific monoclonal antibodies
- describe antigenic sites within CA domain

### Assays

- describe assays for AS and FL MN/CA IX expression
- motivate nucleic acid probes and/or primers
- design probes and/or primers for AS and FL MN/CA IX mRNA
- discuss detection methods for MN AS and FL gene expression products

### Methods of Cancer Therapy Based on MN Alternative Splicing Variants

- discuss cancer therapies based on alternative splicing variants

### MN RNA Interference (MN RNAI)

- motivate RNA interference for MN gene expression inhibition

### MN Gene Therapy Vectors

- discuss gene therapy vectors for MN gene expression inhibition

## Materials and Methods

### Cell Culture, Tissues and Antibodies

- describe cell culture conditions

### Immunofluorescence

- describe immunofluorescence protocol

### Expression Plasmids

- generate expression plasmids

### Transfection

- perform transfection

### Binding of Fluorescent CA Inhibitor

- describe binding assay

### Protein Extraction

- extract proteins from cells and tissues

### Immunoprecipitation and Immunoblotting

- perform immunoprecipitation
- perform immunoblotting

### Reverse Transcription PCR

- perform RT-PCR

## Example 1

### Identification, structure and Expression of a Mouse Splice Variant of CA IX

- identify and sequence mouse splice variant
- analyze and express mouse splice variant

## Example 2

### Identification and structure of a Human splice Variant of CA IX

- identify AS CA9 mRNA in human tissues and cell lines

### Example 3

- detect FL and AS variants of CA9 mRNA in tumor cell lines
- analyze expression of AS variant in normal versus malignant human tissues

### Example 4

- characterize localization and basic characteristics of AS CA IX
- analyze intracellular and extracellular localization of AS CA IX

### Example 5

- analyze functional properties of AS CA IX
- measure catalytic activity of AS CA IX
- analyze effect of AS CA IX on FL CA IX-mediated acidification
- analyze biological consequences of AS CA IX on cell growth and survival

### Discussion

- discuss deregulation of alternative splicing in cancer
- compare expression patterns of FL and AS CA IX in normal and tumor tissues
- analyze implications of AS CA IX for clinical studies using CA9 transcription as a marker of hypoxic tumors
- discuss regulation of splicing events by hypoxia
- analyze functional consequences of AS CA IX on CA IX activity and localization
- discuss potential mechanisms of AS CA IX interference with FL CA IX function
- analyze effects of AS CA IX on cell survival and adaptation to hypoxic stress
- discuss potential physiological situations where AS CA IX may modulate FL CA IX activity
- summarize importance of considering AS CA IX in clinical studies and primer design

### Budapest Treaty Deposits

- deposit hybridoma cell line V/10-VU at BCCM/LMBP
- deposit materials with ATCC under Budapest Treaty

